Context Therapeutics CNTX
NASDAQ CNTX
$0.50 -0.02 (-3.77%)
At close: Aug 21, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Shares Outstanding (Diluted) (2020 - 2026)

Context Therapeutics (CNTX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 64.41 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 115.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 138.28 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 556.90 Mn
10 Context Therapeutics 48.18 Mn 48.18 Mn - 95.18 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 95.18 Mn
Mar 31, 2026 95.18 Mn
Dec 31, 2025 95.19 Mn
Sep 30, 2025 95.19 Mn
Jun 30, 2025 95.19 Mn
Mar 31, 2025 95.19 Mn
Dec 31, 2024 58.42 Mn
Sep 30, 2024 80.48 Mn
Jun 30, 2024 54.96 Mn
Mar 31, 2024 15.97 Mn
Dec 31, 2023 15.97 Mn
Sep 30, 2023 15.97 Mn
Jun 30, 2023 15.97 Mn
Mar 31, 2023 15.97 Mn
Dec 31, 2022 15.97 Mn
Sep 30, 2022 15.97 Mn
Jun 30, 2022 15.97 Mn
Mar 31, 2022 15.97 Mn
Dec 31, 2021 2.83 Mn
Sep 30, 2021 361,067.00